L&C Bio's Q1 2026 Provisional Results: Revenue Up 70.6%, Operating Profit Swings to Black
Revenue 30,295 million KRW, up 70.61% YoY and 23.24% QoQ
Operating profit 5,999 million KRW, swinging from an operating loss of -433 million KRW in the same period last year, up 172.90% QoQ
Net income 2,726 million KRW, controlling interest net income 2,603 million KRW, both turning positive (vs. -642 million and -428 million in the same period last year)
Profit before income tax from continuing operations 3,012 million KRW, turning positive (vs. -872 million in the same period last year)
These provisional consolidated results are prepared under K-IFRS and are subject to change after external audit review